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Abstract: Three new acylated flavonoid C-glycosides, 6'''-(–)-phaseoylspinosin (1), 6'''-(3'''',4'''',5''''-trimethoxyl)-(E)-
cinnamoylspinosin (2), and 6'''-(4''''-O-β-D-gluco-pyranosyl)-benzoylspinosin (3), were isolated from the seeds of Ziziphus 
mauritiana (Rhamnaceae). A further 19 known compounds including eight spinosin analogues (4–11) were also isolated. Their 
structures were elucidated by means of spectroscopic analysis and chemical method. Among spinosin derivatives 1, 2, 4, 7, 8, and 
triterpenoid saponin 14, jujuboside A (14) displayed moderate acetylcholinesterase (AchE) inhibitory activity with an inhibition 
value of 46.2% at a concentration of 1 μM. 
Keywords: Ziziphus mauritiana, Rhamnaceae, seeds, spinosin derivatives, jujuboside A, acetylcholinesterase inhibitory
Introduction 
The genus Ziziphus (Rhamnaceae), comprises of  
approximately 170 species and 12 variants, and is distributed 
in the warm-temperate and subtropical regions throughout the 
world. Thirteen of which are distributed in the southern and 
eastern China. Most Ziziphus species are important sources for 
their edible fruits and medicinal uses.1–3 In the Chinese  
Pharmacopoeia, the dry seeds of Z. jujuba Mill var. spinosa 
(Bunge) Hu ex H. F. Chou, commonly named as Semen 
Ziziphi Spinosae (“Suan-Zao-Ren”), have been used  
traditionally to tranquilize and relax the mind, soothing nerves 
(anxiolytic), and reducing sweating (anti-hydronic) effect. 
Flavonoids, saponins and alkaloids were previously reported 
as isolated from the seeds of Z. jujuba.4–6 
On the other hand, Z. mauritiana Lam., an evergreen shrub 
up to 15 m height, is distributed in the southern China. It is 
also widely growing throughout low-latitudes of Asia, Africa 
and Australia.1,2 The dry seeds have been used as a substitute 
of “Suan-Zao-Ren” (seeds of Z. jujuba var. spinosa) by local 
people in Yunnan province of China. Cyclopepeptide,1,7–12 
triterpenes,1 flavones,1 steroids,1,13 and aliphatic compounds1,14 
have previously been identified from the roots, barks and 
leaves of Z. mauritiana. Interestingly, some of these com-
pounds showed antitumor, anti-HIV,15,16 anti-plasmodial and 
anti-mycobacterial activities.12 However, no chemical study 
was reported on the seeds. As a part of our continuing study of 
the chief phytotherapeutic components of traditional Chinese 
medicines (TCM),17–19 the phytochemical investigation on the 
seeds of Z. mauritiana was carried on. This led to the isolation 
of 11 spinosin derivatives (1–11), along with 11 other known 
compounds (12–22). Compounds 1–3 are new acylated 
flavonoid C-glycosides. The acetylcholinesterase (AChE) 
inhibitory activities of the major isolates were tested, using 
tacrine as the positive control. 
 
Results and Discussion 
The defated MeOH extract of the air-dried seeds of Z.  
mauritiana was applied to column chromatography (CC) over 
Diaion HP20SS, Sephadex LH-20, Chromatorex ODS, 
Toyopearl HW40C, silica gel, MCI-gel CHP20P, and RP-18, 
finally to semi-preparative HPLC, to give three new  
compounds (1–3) and 19 known ones. The known compounds 


























































Figure 1.  Chemical structures of flavonoids 1–3 
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be eight spinosin derivatives [6'''-dihydrophaseoyl- (4),5 6'''-p-
coumaroyl- (5),20 6'''-feruloyl- (6),4 6'''-sinapoyl- (7),20 6'''-(4''''-
O-β-D-glucopyranosyl)-vanilloyl- (8),6 6'''-vanilloyl- (9)21 
spinosin, spinosin (10),4 and isospinosin (11)4], two flavone C-
glycosides [vicenin-2 (12),22 apigenin 6-C-α-L-
rhamnopyranosyl-(1→2)-β-D-glucopyranoside (13),23], one 
triterpenoid saponin [jujuboside A (14)24], six lignans  
[pinoresinol-4,4'-di-β-O-D-glucoside (15),25 erythro-
dihydroxydehydrodiconifery alcohol (16),26 threo-
dihydroxydehydrodiconifery alcohol (17),26 aegineoside 
(18),27 (+)-dehydrodi-coniferyl alcohol-4-O-β-D-glucoside 
(19),28 lariciresinol-4'-O-β-D-glucopyranoside (20)29], one 
alkaloid [zizyphusine (21)30] and one amino acid [tryptophan 
(22) 31], by comparison of their spectroscopic data with the 
reported literature values. 
Compound 1 was isolated as a yellow amorphous powder. 
Its molecular formula was deduced to be C43H50O19 on the 
basis of HREIMS (m/z 870.2999 [M]+). The IR spectrum 
showed absorption bands at 3430 and 1708 cm–1 due to  
hydroxyl and carbonyl groups, respectively. The UV spectrum 
exhibited maximum absorptions at 210, 272, and 332 nm. All 
the protons and carbons of 1 appeared as pair signals in the 1H 
and 13C NMR spectra, which is characteristic of signals arising 
from a spinosin skeleton5. In addition, the remaining 15 carbon 
resonances were further classified by DEPT experiment as six 
quaternary carbons, including a ketone (δC 208.37/208.35, C-
4'''') and a carbonyl (δC 164.95/164.78, C-15''''), three olefinic 
methines, three methylenes including one oxygen-bearing (δC 
76.66, C-11'''') and three quaternary methyl (δC 20.72/20.70, 
15.35/15.28, 19.15/19.11, C-10'''', C-12'''', C-13''''). The 1H 
NMR spectrum displayed the presence of two trans-coupled 
olefinic protons (δH 6.40/6.39, 7.89/7.81, each 1H, d, J = 15.7 
Hz, H-7'''', H-8''''), one singlet olefinic proton at δH 5.50/5.50 
(1H, s, H-14'''')] and three methyl singlets [δH 1.91/1.87, 
0.88/0.87, 1.06/1.03 (each 3H, s)]. The aforementioned data of 
1 were closely related to those of 6'''-dihydrophaseoylspinosin 
(4). The difference between 1 and 4 was the sesquiterpene 
moiety, featuring with an additional ketone in 1, relative to the  
oxygen-bearing methine in 4. In the HMBC spectrum of 1 
(Figure 2), correlations of both H-3'''' (δH 2.61/2.27) and H-5'''' 
(δH 2.76/2.30) with C-4'''' (δC 208.37/208.35), could assign the 
additional ketone (δC 208.37/208.35) to be C-4''''. The above 
data of the sesquiterpene moiety of 1 was essentially identical 
to those of phaseic acid.32 The position of the phaseic acid 
moiety in 1 was revealed to be at C-6"' by the HMBC  
correlation of the H-6"' (δH 3.87/3.62) with the carbonyl  
carbon at δC 164.95/164.78 (C-15''''). Other HMBC and 1H-1H 
COSY correlations (Figure 2), with electronic supplementary 
material further confirmed the structure of 1 as shown in  
Figure 1. 
The relative configuration of compound 1 was determined 
on the basis of the coupling constants and ROESY experiment 
(Figure 2). The trans double bond between C-7'''' and C-8'''' 
was deduced due to the large coupling constant (15.7 Hz) of 
J7'''',8'''', while the cis double bond between C-9'''' and C-14'''' 
was indicated by the ROESY correlations of the olefinic  
H-14'''' (δH 5.50/5.50) with Me-10'''' (δH 1.91/1.87).  In the 
ROESY spectrum of 1, correlations of H-7"" and H-8"" with 
both Me-12"" and Me-13"" were observed. In addition, the  
H-3α"" and H-3β"" were correlated with H-11"" and Me-12"", 
respectively. These data revealed that the unsaturated side 
chain -CH(7)=CH(8)-C(9)=CH(14)-COO(15)- of phaseic acid 
moiety in 1 oriented to the same side of both Me-12"" and  
Me-13"", while the CH2-11"" and O-C(6"") were oriented to 
the opposite side of Me-12"", Me-13"" and C-7"" side chain. 
Alkaline hydrolysis of 1 with 0.5% NaOH yielded spinosin 
(10) and phaseic acid (1a). Compound 1a showed the similar 
NMR spectroscopic data and optical rotation value ([α]20D   – 
Table 1. 1H (600 MHz) and 13C (150 MHz) NMR spectroscopic data of compound 1 ( DMSO-d6; 313 K; δ in ppm) 
pos. δH (J, Hz) δC pos. δH (J, Hz) δC 
2 164.10/163.90, C 2''' 2.84 (t, 8.8) 74.49/74.43, CH 
3 6.79/6.72 (s) 103.12/103.03, CH 3''' 3.06 (m) 76.25/76.19, CH
4 182.23/181.95, C 4''' 2.94 (t, 8.9) 69.12/69.09, CH 
5 160.69/159.57, C 5''' 2.86 (m) 73.51/73.44, CH 
6 108.89/108.81, C 6''' 3.87a/3.62 (m) 62.42/61.65, CH2 
7 165.14/163.67, C 1'''' 81.40/81.37, C 
8 6.77/6.72 (s) 90.65/90.10, CH 2'''' 48.66/48.28, C 
9 157.03/156.92, C 3'''' Hβ 2.61 (m)/Hα 2.27 (m) 52.00/51.96, CH2 
10 104.48/104.08, C 4'''' 208.37/208.35, C 
1' 121.14/121.10, C 5'''' Hβ 2.76 (m)/Hα 2.30 (m) 53.00, CH2 
2',6' 7.91/7.91 (d, 8.8) 128.52/128.49, CH 6'''' 86.04/86.01, C 
3',5' 6.91/6.90 (d, 8.8) 115.93/115.92, CH 7'''' 6.40/6.39 (d, 15.7) 134.22/134.14, CH
4' 161.23, C 8'''' 7.89/7.81 (d, 15.7) 130.35/130.31, CH 
7-OMe 3.89/3.87 (s)a 56.45/56.16, CH3 9'''' 150.60/150.52, C 
1'' 4.70/4.68 (d,10.1) 71.07/70.76, CH 10'''' 1.91/1.87 (s) 20.72/20.70, CH3 
2'' 4.46 (t, 9.4)/4.24b 80.89/79.62, CH 11'''' 3.80/3.53 (m) 76.66, CH2 
3'' 3.46/3.44c 78.70/78.46, CH 12'''' 0.88/0.87 (s) 15.35/15.28, CH3 
4'' 3.17c 70.48/70.41, CH 13'''' 1.06/1.03 (s) 19.15/19.11, CH3 
5'' 3.17c 81.82/81.60, CH 14'''' 5.50 (s) 116.72/116.66, CH 
6'' 3.39c/3.69 (m) 61.55/61.53, CH2 15'''' 164.95/164.78, C 
1''' 4.25 (d, 7.7)b 105.01/104.88, CH 5-OH 13.58/13.46 (s) 
a,boverlapped with each other for the same superscript; coverlapped by solvent. 
 
Figure 2.  Key HMBC and ROESY correlations of compound 1 
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21.7, c 0.098, MeOH) with those of the reported (–)-phaseic 
acid ([α]16D   – 18.0, c 0.10, MeOH).32,33 Therefore, the structure 
of compound 1 was deduced as shown in Figure 1 and named 
6'''-(–)-phaseoylspinosin. 
Compound 2, a yellow amorphous powder, has a molecular 
formula determined to be C40H44O19, as deduced from the 
HREIMS (m/z 828.2475, calcd. for 828.2477). The 1H and 13C 
NMR spectra of 2 exhibited the characteristic features of a 
spinosin skeleton. In addition, a set of signals arising from one 
carbonyl (δC 166.08/165.96, C-9''''), three methoxyl [δC 
55.98/55.90 (OCH3  2), 60.08/60.06), four olefinic methines 
[δC 105.53/105.18 (CH  2), 144.32/144.15 (CH), 
116.80/116.29 (CH)], and four aromatic quaternary carbons 
[δC 129.46/129.21 (C), 152.98/152.87 (C  2), 139.43/139.38 
(C)] were observed in the 13C NMR (DEPT) spectra. The 1H 
NMR spectrum displayed the existence of a symmetric 
1,3,4,5-tetra-substituted aromatic ring [δH 6.86/6.69 (2H, s)] , 
one trans double bond [δH 7.22/7.06, 6.40/6.30 (each 1H, d, J 
= 15.8 Hz, H-7'''', H-8'''')] and three methoxyl groups [δH 
3.82/3.79 (6H, s, 3'''', 5''''-OMe); δH 3.71/3.70 (3H, s, 4''''-
OMe)]. The aforementioned data suggested that 2 was a  
spinosin derivative acylated with a 3,4,5-trimethoxy-(E)-
cinnamoyl moiety.34 In the HMBC spectrum of 2 (Figure 3), 
correlations between the H-6''' (δH 4.05/3.65) and C-9'''' (δC 
166.08/165.96) indicated the linkage of the cinnamoyl moiety 
with C-6''' (δC 62.41/62.29) of spinosin unit. Other HMBC 
correlations (Figure 3) were used to further confirm the  
structure of 2 as shown in Figure 1. Thus, the structure of 
compound 2 was determined as 6'''-(3'''',4'''',5''''-trimethoxy)-
(E)-cinnamoylspinosin. 
Compound 3 was isolated as a yellow amorphous powder. 
On the basis of the HREIMS (m/z 890.2523, calcd. for 
Table 2. 1H (600 MHz) and 13C (150 MHz) NMR spectroscopic data of compounds 2 and 3 ( DMSO-d6; 313 K; δ in ppm) 
 
position 
2  3 
δH (J, Hz) δC δH (J, Hz) δC 
2 164.10/163.89, C 163.89/163.84, C 
3 6.69/6.51 (s) 103.17/102.92, CH 6.70/6.46 (1H, s) 102.89/102.74, CH 
4 182.22/181.78, C 182.23/181.69, C
5 160.81/159.46, C 160.70/159.48, C 
6 108.76/108.74, C 108.81/108.66, C 
7 165.23/163.60, C 165.09/163.56, C 
8 6.69/6.69 (s) 90.55/89.88, CH 6.64/6.53 (1H, s) 90.47/89.85, CH 
9 157.01/156.85, C 156.91/156.73, C 
10 104.45/103.96, C 104.41/103.90, C 
1' 121.13/121.09, C 121.02/120.86, C 
2',6' 7.80/7.79 (d, 8.8) 128.47/128.39, CH 7.82/7.75 (d, 8.7) 128.46/128.41, CH 
3',5' 6.88/6.83 (d, 8.8) 115.76/115.70, CH 6.93/6.92 (d, 8.7) 115.77/115.66, CH 
4' 161.23/161.15, C 161.39/161.34, C 
7-OCH3 3.90/3.87 (s)  56.40/ 56.10, CH3 3.87/3.80 (s) 56.37/56.09, CH3 
1'' 4.70/4.69 (d, 9.8) 70.98/ 70.64, CH 4.69/4.68 (d, 9.7) 71.02/70.67, CH 
2'' 4.49 (t, 9.3)/4.25 (t, 9.3)  81.65/ 80.13, CH 4.45 (t, 9.4)/4.23 (t, 9.4) 81.59/80.26, CH 
3'' 3.44 (m) 78.81/78.63, CH 3.43a 78.49, CH 
4'' 3.16a 70.33/70.27, CH 3.16a 70.33/70.27, CH 
5'' 3.16a 81.93, CH 3.16a 81.91/81.90, CH 
6'' 3.82b/3.38 (m) 61.53/61.49, CH2 3.70 (1H, m)/3.37a 61.52/61.48, CH2 
1''' 4.31/4.30 (d, 7.3) 105.76/105.70, CH 4.28/4.27 (d, 7.8) 105.61/105.16, CH 
2''' 2.93 (t, 8.3)/2.90 (t, 8.3) 74.41/74.38, CH 2.94 (t, 8.1)/2.89 (t, 8.1) 74.54/74.51, CH 
3''' 3.11 (m) 76.31, CH 3.11c 76.15/76.11, CH 
4''' 3.09 (m) 68.86/68.51, CH 3.08c 68.96/68.84, CH
5''' 2.98 (m) 73.25/72.94, CH 2.97 (1H, m) 73.15, CH 
6''' 4.05/3.65 (m) 62.41/62.29, CH2 4.04 (1H, m)/3.61 (1H, m) 62.74/62.21, CH2 
1'''' 129.46/129.21, C 122.93/122.80, C 
2'''' 6.86/6.69 (s) 105.53/105.18, CH 7.61/7.49 (d, 8.7) 130.83/130.64, CH 
3'''' 152.98/152.87, C 7.04/6.95 (d, 8.8) 115.88/115.86, CH 
4'''' 139.43/139.38, C 161.00/160.95, C 
5'''' 152.98/152.87, C 7.04/6.95 (d, 8.8) 115.88/115.86, CH 
6'''' 6.86/6.69 (s) 105.53/105.18, CH 7.61/7.49 (d, 8.7) 130.83/130.64, CH 
7'''' 7.22/7.06 (d, 15.8) 144.32/144.15, CH 164.74/164.65, C 
8'''' 6.40/6.30 (d, 15.8) 116.80/116.29, CH 
9'''' 166.08/165.96, C 
3''''-OCH3 3.82/3.79 (s)b 55.98/55.90, CH3 
4''''-OCH3 3.71/3.70 (s) 60.08/60.06, CH3 
5''''-OCH3 3.82/3.79 (s)b 55.98/55.90, CH3 
1''''' 5.00/4.96 (d, 7.5) 100.03/ 99.91, CH 
2''''' 3.28a 73.18, CH 
3''''' 3.34a 77.15/76.59, CH 
4''''' 3.18a 69.71/69.68, CH 
5''''' 3.44a 78.77/78.79, CH 
6''''' 3.70 (1H, m)/3.50a 60.69/60.67, CH2 
5-OH 13.59 (s) 13.64 (s)
aoverlapped by solvent; boverlapped with each other. 
 
Figure 3.  Key HMBC (H→C) correlations of compound 2 
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890.2481), its molecular formula was determined to be 
C41H46O22. The 1H and 13C NMR spectra also showed the  
presence of a spinosin skeleton in 3. In addition, an AA'BB' 
coupled aromatic system [δH 7.61/7.49 (2H, d, J = 8.7 Hz, H-
2'''', 6'''') and δH 7.04/6.95 (2H, d, J = 8.8 Hz, H-3'''', 5'''')] was 
observed in the 1H NMR spectrum, together with an additional 
anomeric proton at δH 5.00/4.96 (1H, d, J = 7.5 Hz). The 13C 
NMR (DEPT) spectra showed the occurance of a carboxyl (δC 
164.74/164.65, C-7'''') and six aromatic carbons arising from a 
benzoyl unit, and six oxygen-bearing alphatic carbons due to a 
glucosyl moiety. The above data revealed that compound 3 
was an analogue of 8,6 except for the absence of one methoxyl 
group associated with the benzoyl moiety, related to 8. The 
HMBC correlations of the anomeric proton at H-1''''' (δH 
5.00/4.96) with C-4'''' (δC 161.00/160.95), H-2'''',6'''' (δH 
7.61/7.49) with C-4'''' (δC 161.00/160.95) and C-7'''' 
(164.74/164.65), and H-3'''',5'''' (δH 7.04/6.95) with C-1'''' (δC 
122.93/122.80) suggested the additional glucosyl unit was 
connected to the benzoyl C-4'''' position. The linkage of the 
benzoyl group with C-6''' of spinosin moiety were supported 
by the HMBC correlations from H-6''' (δH 4.04/3.61) to C-7'''' 
(δC 164.74/164.65). Consequently, the structure of compound 
3 was determined to be 6'''-(4''''-O-β-D-glucopyranosyl)-
benzoylspinosin. 
It is note that the 1H and 13C NMR data of the spinosin (10) 
and its derivatives 1–9 exhibited doubling of signals at room 
temperature due to the rotational isomers produced by the  
rotational barriers 7-OCH3 in flavones-6-C-glycoside.4 
As compared with the positive control, tacrine (59.0%), 
compounds 1, 2, 4, 7 and 14 displayed moderate AChE  
inhibitory activity with inhibition values of 24.9%, 33.9%, 
26.9%, 28.8% and 46.2%, respectively, at a concentration of 1 
µM, by the spectrophotometric method developed by Ellman 
et al.35 with slight modification. Interstingly, AChE inhibition 
of compound 8 was only 7.8% at 1 µM concentration. 
 
Experimental Section 
General Experimental Procedures. Optical rotations were 
determined with a Jasco P-1020 polarimeter. UV (in MeOH) 
spectra were obtained with the Shimadzu UV-2401 PC  
spectraphotometer. The Bruker Tensor-27 infrared  
spectrophotometer was used for IR spectra as KBr pellets. 
ESIMS and HREIMS spectra were recorded on API QSTAR 
Pulsar spectrometer and Waters Autospec Premier P776,  
respectively. 1D and 2D NMR spectra were performed on 
Bruker Avance III-600MHz spectrometers with TMS as an 
internal standard. Semi-preparative and preparative HPLC 
studies were performed on an Agilent 1260 and Gilson GX-
27X liquid chromatograph. TLC was performed on precoated 
TLC plates (0.2–0.25 mm thickness, GF254 Si gel 60, Qing-
dao Marine Chemical Co., Ltd.) with compounds visualized by 
spraying the dried plates with 10% aqueous H2SO4 followed 
by heating until the plate was dry. Silical gel (200–300 mesh, 
Qingdao Marine Chemical Co., Ltd.), Diaion HP20SS 
(Mitsubishi Chemical Co., Ltd.), Lichroprep RP-18 (40–63 μm, 
Merck), Sephadex LH-20 (25–100 μm, Pharmacia Fine  
Chemical Co., Ltd.), Chromatorex ODS (100–200 mesh, Fuji 
Silysia Chemical Co., Ltd.), Toyopearl HW40C (50–100 μm, 
Tosoh Co., Ltd.) and MCI-gel CHP20P (75–150 μm, 
Mitsubishi Chemical Co., Ltd.) were used for column  
chromatography (CC). The chemicals used for bioassay  
including S-acetylthiocholine iodide, S-butyrylthiocholine 
iodide, 5,5'-dithio-bis-(2-nitro-benzoic) acid (DTNB), and 
AChE was derived from human erythrocytes purchased from 
Sigma Chemicals. 
 
Plant Material. The seeds of Z. mauritiana were collected 
from the herbal medicine market in Kunming, Yunnan  
Province, China, in July, 2011, and identified by Prof.  
Chong-Ren Yang (Kunming Institute of Botany, Chinese 
Academy of Sciences). A voucher sample (KIB-Z-00331) has 
been deposited in the State Key Laboratory of Phytochemistry 
and Plant Resources in West China, Kunming Institute of 
Botany, Chinese Academy of Sciences. 
 
Extraction and Isolation. The air-dried seeds (20 kg) of Z. 
mauritiana were powdered, and extracted three times per 2 
hours with MeOH at 60 °C. The extracts was suspended in 
H2O and degreased by petroleum ether. The H2O-soluble layer 
(1.2 kg) was applied to a Diaion HP20SS column, eluting with 
H2O/MeOH (1:0→0:1), to give fractions I–IV. Compound 10 
(13.6 g) was obtained by crystallization from fraction III, and 
the remaining part was further subjected to Sephadex LH-20 
chromatography column, eluting with MeOH-H2O (10:90, 
30:70, 50:50, 70:30 and 100:0) to derive the subfractions (III-1 
and III-2). Subfraction III-1 (20.5 g) was subjected to  
Chromatorex ODS column, and eluted with H2O/MeOH (1:0
→0:1), to derive seven fractions (III-1-1–7). Fraction III-1-3 
(2.0 g) was subjected to Sephadex LH-20, MCI-gel, RP-18, 
silica gel and semi-preparative HPLC, and obtained com-
pounds 12 (7 mg), 13 (8 mg), 16 (4 mg), 17 (5 mg), 18 (31 mg) 
and 22 (26 mg). Fraction III-1-4 (5.0 g) was successively sepa-
rated by Toyopearl HW40C, Sephadex LH-20, silica gel and 
Sephadex LH-20, then compound 3 (40 mg), 11 (40 mg), 19 
(69 mg) and 20 (63 mg) were obtained. Compound 8 (10 mg) 
was obtained from Fr. III-1-6 (1.1 g) by repeated CC over 
Toyopearl HW40C, MCI, RP-18 and finally purified by HPLC 
using MeCN-H2O (18:82) as elution. The sub-fraction III-1-7 
(3.2 g) was successively subjected to Toyopearl HW40C, 
MCI-gel, Sephadex LH-20, and silica gel to afford compounds 
1 (139 mg), 4 (170 mg), 7 (113 mg) and 15 (47 mg). Further-
more, fraction III-2 (12.6 g) was successively separated by 
Rp-18, Toyopearl HW40C and preparative HPLC using 
MeCN-H2O, and purified by semi-preparative HPLC using 
MeCN-H2O, and isolate compound 9 (4 mg). Similarly, Frac-
tion IV was subjected to Sephadex LH-20 chromatography 
column, and eluted with MeOH-H2O (30:70, 50:50, 70:30 and 
90:10)  and was successively separated by Toyopearl HW40C, 
Rp-18, silica gel, Sephadex LH-20, MCI-gel and silica gel 
were used to isolate compounds 2 (280 mg), 5 (11 mg), 6 (200 
mg), 14 (137 mg) and 21 (109 mg). 
 
6'''-(–)-Phaseoylspinosin (1): yellow amorphous powder; 
[α] 20D   – 31.7 (c 0.2, MeOH); UV (MeOH) λmax (log ε) 332 
(4.31), 272 (4.59) and 210 (4.56) nm; IR (KBr) νmax 3430, 
2928, 2883, 1708, 1653, 1607, 1511, 1491, 1448, 839 and 779 
cm–1, 1H and 13C NMR data see Table 1; ESIMS m/z 893 [M + 
Na]+; HREIMS m/z 870.2999 (calcd. for C43H50O19 [M]+, 
870.2946). 
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6'''-(3'''',4'''',5''''-Trimethoxy)-cinnamoylspinosin (2): 
yellow amorphous powder; [α]19D   – 63.4 (c 0.2, MeOH); UV 
(MeOH) λmax (log ε) 309 (4.52) and 206 (4.65) nm; IR (KBr) νmax 3411, 2938, 1706, 1654, 1607, 1508, 1491, 1450, 836 and 
778 cm–1, 1H and 13C NMR data see Table 2; ESIMS m/z 851 




yellow amorphous powder; [α]19D   – 83.2 (c 0.2, MeOH); UV 
(MeOH) λmax (log ε) 333 (4.31), 307 (4.25), 251 (4.42) and 204 
(4.68) nm; IR (KBr) νmax 3423, 2919, 1704, 1653, 1608, 1510, 
1491, 1449, 839 and 770 cm–1, 1H and 13C NMR data see 
Table 2; ESIMS m/z 913 [M + Na]+ ; HREIMS m/z 890.2523 
(calcd. for C41H46O22 [M]+, 890.2481). 
 
Alkaline Hydrolysis of 1–3. A solution of compound 1 (50 
mg) in 0.5% NaOH (2 mL) was stirred at 65 °C for 1 h. The 
reaction mixture was partitioned with H2O and n-BuOH,  
successively. Further CC over Sephadex LH-20 to afford 
spinosin (20 mg) from the n-BuOH layer. The water layer was 
neutralized with 0.5 N HCl solution and extracted with CHCl3. 
The organic layer was subjected to preparative TLC over silica 
gel (CHCl3-MeOH, 20:1) to afford (–)-phaseic acid (1a, 1.9 
mg): white amorphous powder; [α]20D   – 21.7 (c 0.098, MeOH); 
ESIMS m/z 303 [M + Na]+; 1H NMR (600 MHz, DMSO-d6) : δH 0.87 (3H, s, H-12), 1.07 (3H, s, H-13), 1.97 (3H, s, H-10), 
2.29 (1H, d, J = 17.6 Hz, H-3a), 2.50 (1H, overlapped with 
solvent, H-5a), 2.67 (1H, d, J = 17.6 Hz, H-3b), 2.78 (1H, d, J 
= 17.4 Hz, H-5b), 3.51 (1H, d, J = 7.4 Hz, H-11a), 3.75 (1H, d, 
7.4 Hz, H-11b), 5.70 (1H, s, H-14), 6.35 (1H, d, J = 15.6 Hz, 
H-7), 8.02 (1H, s, J = 15.6 Hz, H-8). 13C NMR (150 MHz, 
DMSO-d6): δC 15.49 (C-12), 19.30 (C-13), 20.91 (C-10), 
48.31 (C-2), 52.04 (C-3), 53.13 (C-5), 76.71 (C-11), 81.35 (C-
1), 86.14 (C-6), 121.34 (C-14), 131.14 (C-8), 132.26 (C-7), 
150.8 (C-9), 168.3 (C-15), 208.71 (C-4)]. TLC analysis also 
indicated the presence of spinosin in the aqueous layer 
(CHCl3-MeOH-H2O 8:2:0.2, Rf 0.23). Similarly to 1, alkaline 
hydrolysis of 2 and 3 (each 10 mg) was carried out, 
separatedly. The existence of spinosin was confirmed by TLC 
analysis (CHCl3-MeOH-H2O 8:2:0.2, Rf 0.23). 
 
Acid Hydrolysis of 1–3. Compounds 1–3 (each 10 mg) was 
dissolved in 2 N HCl (2 mL) and refluxed at 80 °C for 10 h. 
The reaction mixture was neutralized with Amberlit IRA-401 
and a sugar residue was obtained. Identification of D-glucose 
was performed by comparison of OD (+) with authentic 
samples. 
 
Acetylcholinesterase (AChE) Inhibitory Activity. The 
AChE inhibitory activity was assayed using the spectrophoto-
metric method developed by Ellman et al.34 with slightly  
modification. In brief, the reaction mixture (200 μL in total) 
containing phosphate buffer (pH 8.0), testing compound (50 
µM in DMSO), and AChE (0.02 U/mL), was incubated for 20 
min (30 °C). Then, the reaction was initiated by the addition of 
40 μL of solution containing DTNB (0.625 mM) and 
acetylthiocholine iodide (0.625 mM). The hydrolysis of 
acetylthiocholine was monitored at 405 nm every 30 seconds 
for one hour. Tacrine was used as positive control with final 
concentration of 0.333 μM. All the reactions were performed 
in triplicate. The percentage inhibition was calculated as  
follows:  
% inhibition = (E – S) / E × 100 
(E is the activity of the enzyme without test compound and 
S is the activity of enzyme with the test compound). 
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